Virtus ETF Advisers’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-6,118
| Closed | -$226K | – | 478 |
|
|
2022
Q3 | $226K | Buy |
6,118
+50
| +0.8% | +$1.85K | 0.09% | 307 |
|
|
2022
Q2 | $115K | Sell |
6,068
-2,448
| -29% | -$46.4K | 0.04% | 397 |
|
|
2022
Q1 | $230K | Sell |
8,516
-499
| -6% | -$13.5K | 0.1% | 189 |
|
|
2021
Q4 | $203K | Buy |
9,015
+2,312
| +34% | +$52.1K | 0.08% | 202 |
|
|
2021
Q3 | $176K | Sell |
6,703
-353
| -5% | -$9.27K | 0.08% | 299 |
|
|
2021
Q2 | $226K | Sell |
7,056
-1,891
| -21% | -$60.6K | 0.09% | 259 |
|
|
2021
Q1 | $315K | Buy |
8,947
+164
| +2% | +$5.77K | 0.13% | 234 |
|
|
2020
Q4 | $282K | Buy |
8,783
+2,219
| +34% | +$71.2K | 0.12% | 243 |
|
|
2020
Q3 | $247K | Sell |
6,564
-899
| -12% | -$33.8K | 0.13% | 266 |
|
|
2020
Q2 | $334K | Buy |
+7,463
| New | +$334K | 0.16% | 282 |
|